CXCR4 and adrenal cortex carcinoma: Despite these two rather unfavorable aspects regarding the practicability of CXCR4-RLT in solid tumors, one has to consider that a substantial portion of patients were diagnosed with difficult-to-treat tumor entities, including ACC.